Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Small Cell Lung Cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Prognosis
1270 results:

  • 1. Efficacy and safety of neoadjuvant immunotherapy plus chemotherapy followed by adjuvant immunotherapy in resectable non-small cell lung cancer: a meta-analysis of phase 3 clinical trials.
    Zhang W; Liang Z; Zhao Y; Li Y; Chen T; Li W; Chen Y; Wu P; Zhang H; Fang C; Li L
    Front Immunol; 2024; 15():1359302. PubMed ID: 38646542
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Targeted therapeutic options in early and metastatic NSCLC-overview.
    Gálffy G; Morócz É; Korompay R; Hécz R; Bujdosó R; Puskás R; Lovas T; Gáspár E; Yahya K; Király P; Lohinai Z
    Pathol Oncol Res; 2024; 30():1611715. PubMed ID: 38605928
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A phenotypic screening approach to target p60AmotL2-expressing invasive cancer cells.
    Fonseca P; Cui W; Struyf N; Tong L; Chaurasiya A; Casagrande F; Zhao H; Fernando D; Chen X; Tobin NP; Seashore-Ludlow B; Lundqvist A; Hartman J; Göndör A; Östling P; Holmgren L
    J Exp Clin Cancer Res; 2024 Apr; 43(1):107. PubMed ID: 38594748
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Association of systemic inflammatory markers with prognosis in erlotinib-treated egfr-mutant non-small cell lung cancer.
    Yetişir AE; Paydaş S; Büyükşimşek M; Oğul A; Kolsuz İ; Kıdı MM
    J Cancer Res Ther; 2024 Jan; 20(1):285-288. PubMed ID: 38554335
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Improved Outcomes in Resectable Advanced or Recurrent lung cancer].
    Goto Y
    Gan To Kagaku Ryoho; 2024 Mar; 51(3):237-239. PubMed ID: 38494799
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Label-free fluorescent sensor for sensitive detection of ctDNA based on water stabilized CsPbBr
    Yang X; Zhao L; Yang S; Tang M; Fa H; Huo D; Hou C; Yang M
    Biosens Bioelectron; 2024 Jun; 253():116165. PubMed ID: 38437747
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. STK11/LKB1 alterations worsen the poor prognosis of KRAS mutated early-stage non-squamous non-small cell lung carcinoma, results based on the phase 2 IFCT TASTE trial.
    Baptiste Oudart J; Garinet S; Leger C; Barlesi F; Mazières J; Jeannin G; Audigier-Valette C; Morot-Sibilot D; Langlais A; Amour E; Mathiot N; Birsen G; Blons H; Wislez M
    Lung Cancer; 2024 Apr; 190():107508. PubMed ID: 38428265
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. prognosis of non-small cell lung cancer with postoperative regional lymph node recurrence.
    Ohtaki Y; Nagashima T; Okano N; Kubo N; Ohtaka T; Sunaga N; Sakurai R; Miura Y; Nakazawa S; Kawatani N; Yazawa T; Yoshikawa R; Narusawa E; Shirabe K
    Thorac Cancer; 2024 Apr; 15(11):859-866. PubMed ID: 38414316
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Efficacy of bevacizumab through an indwelling pleural catheter in non-small cell lung cancer patients with symptomatic malignant pleural effusion.
    Zeng H; Zhang Y; Tan S; Huang Q; Pu X; Tian P; Li Y
    BMC Pulm Med; 2024 Feb; 24(1):89. PubMed ID: 38365707
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. 2021 WHO Classification of lung cancer: Molecular Biology Research and Radiologic-Pathologic Correlation.
    Sasaki T; Kuno H; Hiyama T; Oda S; Masuoka S; Miyasaka Y; Taki T; Nagasaki Y; Ohtani-Kim SJ; Ishii G; Kaku S; Shroff GS; Kobayashi T
    Radiographics; 2024 Mar; 44(3):e230136. PubMed ID: 38358935
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Bilateral diffuse metastases in advanced lung adenocarcinoma harboring egfr mutations was associated with a favorable prognosis to egfr-TKIs.
    Gu Z; Huang P; Zhao J; Luo C; Liao L; Liu A; Huang L
    Int J Cancer; 2024 Jun; 154(11):1979-1986. PubMed ID: 38353428
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Phosphorylation of AGO2 by TBK1 Promotes the Formation of Oncogenic miRISC in NSCLC.
    Zhao X; Cao Y; Lu R; Zhou Z; Huang C; Li L; Huang J; Chen R; Wang Y; Huang J; Cheng J; Zheng J; Fu Y; Yu J
    Adv Sci (Weinh); 2024 Apr; 11(15):e2305541. PubMed ID: 38351659
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The interplay between autophagy and apoptosis: its implication in lung cancer and therapeutics.
    Biswas U; Roy R; Ghosh S; Chakrabarti G
    Cancer Lett; 2024 Mar; 585():216662. PubMed ID: 38309614
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Upfront Multiplex Gene Test Helps Prolong Survival in Advanced Non-small cell lung cancer.
    Kanasaki H; Ozawa Y; Nakamura N; Nagasaki K; Matsuyama W; Akahori D; Niwa M; Ogasawara T; Sato J
    Anticancer Res; 2024 Feb; 44(2):723-730. PubMed ID: 38307579
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The state of the art of egfr exon 20 insertions in non-small cell lung cancer: Diagnosis and future perspectives.
    Dorta-Suárez M; de Miguel M; Amor-Carro O; Calderón JM; González-Ortega M; Rodríguez-Abreu D
    Cancer Treat Rev; 2024 Mar; 124():102671. PubMed ID: 38281403
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Effectiveness of high-dose third-generation egfr-tyrosine kinase inhibitors in treating egfr-mutated non-small cell lung cancer patients with leptomeningeal metastasis.
    Wu H; Zhang Q; Zhai W; Chen Y; Yang Y; Xie M; Huang Z; Xu Y; Li H; Gong L; Yu S; Fan Y; Chen K
    Lung Cancer; 2024 Feb; 188():107475. PubMed ID: 38266613
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Germline USP36 Mutation Confers Resistance to egfr-TKIs by Upregulating MLLT3 Expression in Patients with Non-small cell lung cancer.
    Guan S; Chen X; Wei Y; Wang F; Xie W; Chen Y; Liang H; Zhu X; Yang Y; Fang W; Huang Y; Zhao H; Zhang X; Liu S; Zhuang W; Huang M; Wang X; Zhang L
    Clin Cancer Res; 2024 Apr; 30(7):1382-1396. PubMed ID: 38261467
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The emerging roles of CEACAM6 in human cancer (Review).
    Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
    Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Deep learning-radiomics integrated noninvasive detection of epidermal growth factor receptor mutations in non-small cell lung cancer patients.
    Kim S; Lim JH; Kim CH; Roh J; You S; Choi JS; Lim JH; Kim L; Chang JW; Park D; Lee MW; Kim S; Heo J
    Sci Rep; 2024 Jan; 14(1):922. PubMed ID: 38195717
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Non-invasive decision support for clinical treatment of non-small cell lung cancer using a multiscale radiomics approach.
    Zhang X; Zhang G; Qiu X; Yin J; Tan W; Yin X; Yang H; Wang H; Zhang Y
    Radiother Oncol; 2024 Feb; 191():110082. PubMed ID: 38195018
    [TBL] [Abstract] [Full Text] [Related]  


    of 64.